PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.

MLA

Long, Li-Li, et al. “PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.” Cancer Research, vol. 83, no. 4, Feb. 2023, pp. 568–81. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-22-1740.

APA

Long, L.-L., Ma, S.-C., Guo, Z.-Q., Zhang, Y.-P., Fan, Z., Liu, L.-J., Liu, L., Han, D.-D., Leng, M.-X., Wang, J., Guo, X.-J., Tan, J.-L., Cai, X.-T., Lin, Y., Pan, X., Wu, D.-H., Bai, X., & Dong, Z.-Y. (2023). PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer Research, 83(4), 568–581. https://doi.org/10.1158/0008-5472.CAN-22-1740

Chicago

Long, Li-Li, Si-Cong Ma, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Li-Juan Liu, Li Liu, et al. 2023. “PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.” Cancer Research 83 (4): 568–81. doi:10.1158/0008-5472.CAN-22-1740.